Provided by Tiger Trade Technology Pte. Ltd.

Neuronetics Inc.

1.56
+0.14009.86%
Post-market: 1.52-0.0400-2.56%18:45 EST
Volume:1.77M
Turnover:2.72M
Market Cap:106.84M
PE:-1.88
High:1.60
Open:1.44
Low:1.44
Close:1.42
52wk High:5.92
52wk Low:1.25
Shares:68.49M
Float Shares:43.21M
Volume Ratio:1.01
T/O Rate:4.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8300
EPS(LYR):-1.3773
ROE:-218.99%
ROA:-21.21%
PB:3.91
PE(LYR):-1.13

Loading ...

Neuronetics Inc - on Jan 15, Entered Amendment No. 4 to Credit Agreement - SEC Filing

THOMSON REUTERS
·
Jan 22

Neuronetics Amends Credit Agreement With Perceptive Credit Holdings

Reuters
·
Jan 22

Neuronetics Awards Cash Bonuses and RSUs to Top Executives

Reuters
·
Jan 07

TAC-STIM Demonstrates Significant Performance Improvements in Active-Duty United States Air Force Airmen

GlobeNewswire
·
Dec 02, 2025

TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression

GlobeNewswire
·
Nov 12, 2025

Neuronetics President, CEO Keith Sullivan to Retire

Dow Jones
·
Nov 04, 2025

Neuronetics Inc. Showcases Growth Strategy and Mental Health Solutions in Corporate Presentation

Reuters
·
Nov 04, 2025

Neuronetics Q3 revenue misses estimates

Reuters
·
Nov 04, 2025

Neuronetics Q3 EPS $(0.13) Misses $(0.10) Estimate, Sales $37.297M Miss $38.055M Estimate

Benzinga
·
Nov 04, 2025

BRIEF-Neuronetics Q3 Gross Margin 45.9%

Reuters
·
Nov 04, 2025

Neuronetics Inc - CEO Keith J. Sullivan to Retire June 2026

THOMSON REUTERS
·
Nov 04, 2025

Neuronetics Outlook Q4 Revenue USD 40-43 Million

THOMSON REUTERS
·
Nov 04, 2025

Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan

THOMSON REUTERS
·
Nov 04, 2025

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Nov 01, 2025

Neuronetics Inc expected to post a loss of 13 cents a share - Earnings Preview

Reuters
·
Oct 31, 2025

Neuronetics Inc - Partnership Pilot Launched in Q4 2025, Expansion Planned for 2026

THOMSON REUTERS
·
Oct 30, 2025

Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence

GlobeNewswire
·
Oct 30, 2025

Neuronetics Inc - Coverage Effective Oct 1 for Fee-for-Service Medicaid Members

THOMSON REUTERS
·
Sep 17, 2025

Neuronetics Inc - New York Medicaid to Cover Tms Services for Adults With Mdd

THOMSON REUTERS
·
Sep 17, 2025

Neuronetics announces New York State Medicaid to begin covering TMS services

TIPRANKS
·
Sep 17, 2025